Early bird pricing has been extended! Register today! https://t.co/BysC0RunUh https://t.co/4Ar0kHa4tt

Palmoplantar pustulosis (PPP) is difficult to treat; w/ few reports of JAKi efficacy. Now a report of 21 PPP pts given bimekizumab and 17 patients showed complete clearance in 1 to 4 months. SAPHO pts had complete clearance of skin & improved joint pain https://t.co/tYpHCxFOBI https://t.co/i4o3KnGlPY

UK Dermatology Registry of 13 699 Psoriasis pts on biologics (25K biologic exposures) found 1% risk of paradoxical eczema. Biologics included inhibitors of TNF, IL-17, IL12/23, IL-23. Lowest risk w/ IL-23i (0.56/100kPY), and higher w/ IL-17i (1.22) https://t.co/fOX6VGJQLk https://t.co/u1p1sidCte

Post-Menopausal Osteoporosis Review and Recommendations A recent New England Journal review of post-menopausal osteoporosis (OP) provided updated information, strategies and a review of guidelines and clinical recommendations. https://t.co/TkJjsX98Ww https://t.co/2Hi72GjEHM

ICYMI: The Heart of Lupus Few people are aware of the EULAR recommendations1 for cardiovascular (CV) risk management in systemic lupus erythematosus (SLE) published in 2022. The recommendations had 4 overarching principles... https://t.co/5I5eYNqHIu https://t.co/W6VzUFs6kN

Withdraw DMARDS after remission? Considering withdrawing DMARDs after remission is on our minds. When patients inquire about tapering or stopping DMARDs while doing well, we often lack a clear-cut answer. https://t.co/wqcCff7kjx https://t.co/vq9ee1dZNX

Calcineurin Inhibitors in Lupus Nephritis Dr. Kathryn Dao discusses abstract 1509 with Dr. Gabriel Figueroa-Parra at the 2023 ACR Convergence meeting in San Diego, CA. https://t.co/1sjvCUyvD9 https://t.co/kocmtM1j6o

Pneumocystis Jiroveci Pneumonia (PJP) Risk https://t.co/OTG9Ud1adu https://t.co/jIhdwws0Un

ICYMI: Are Rheumatologists doing Enough for Cervical Cancer? https://t.co/afg5YL3RCN https://t.co/VRyKh6VgmS

Even low-dose, short-term steroid use increases the risk of serious CV events Dr. Meral El Ramahi (Nashville, TN) reports on abstract 2430 presented at the 2023 ACR Convergence meeting in San Diego, CA. https://t.co/apgxXeVw1U https://t.co/zPiUCqtJlf

ILD Guidelines Indicators to Screen Dr. Mike Putman reports from the 2023 ACR Convergence meeting in San Diego, CA. https://t.co/PDE3eZ0Men https://t.co/7xlwrspq9U

ICYMI: How early is early in PsA? Guidelines for the management of PsA recommend the early referral of patients with the suspected condition for early assessment and treatment. https://t.co/9d6WONarwL https://t.co/lNNKzblkEP